ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR
HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION

a 2019

ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION

KAMASOVA, M.; J. VACLAVIK; T. VACLAVIK; E. KOCIANOVA; Jiří JARKOVSKÝ et al.

Základní údaje

Originální název

ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION

Autoři

KAMASOVA, M.; J. VACLAVIK; T. VACLAVIK; E. KOCIANOVA; Jiří JARKOVSKÝ ; Klára BENEŠOVÁ; L. JELINEK a M. TABORSKY

Vydání

29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), 2019

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 4.171

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/19:00113707

Organizační jednotka

Přírodovědecká fakulta

ISSN

DOI

https://doi.org/10.1097/01.hjh.0000573932.16624.68

UT WoS

000481429700921

Klíčová slova anglicky

hypertensive patients; hypertrophy

Štítky

rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 21. 4. 2020 15:43, Mgr. Marie Novosadová Šípková, DiS.

Anotace

V originále

According to current registry data, 37% of hypertensive patients reach target blood pressure level. The failure to achieve target blood pressure level cause cardiovascular complications and mortality. Poorly treated arterial hypertension is long-term asymptomatic condition leading to hypertension-mediated organ damage (HMOD), that can be detected by imaging methods and laboratory tests. The aim of our study was to find out the difference in left ventricular (LV) mass values in nonadherent and adherent hypertensive patients.

Citovat

KAMASOVA, M.; J. VACLAVIK; T. VACLAVIK; E. KOCIANOVA; Jiří JARKOVSKÝ; Klára BENEŠOVÁ; L. JELINEK a M. TABORSKY. ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION. In 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH). 2019. ISSN 0263-6352. Dostupné z: https://doi.org/10.1097/01.hjh.0000573932.16624.68.

@proceedings{1648037,
   author = {Kamasova, M. and Vaclavik, J. and Vaclavik, T. and Kocianova, E. and Jarkovský, Jiří and Benešová, Klára and Jelinek, L. and Taborsky, M.},
   booktitle = {29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH)},
   doi = {https://doi.org/10.1097/01.hjh.0000573932.16624.68},
   keywords = {hypertensive patients; hypertrophy},
   language = {eng},
   title = {ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION},
   url = {https://journals.lww.com/jhypertension/Abstract/2019/07001/ADHERENCE_TO_ANTIHYPERTENSIVE_MEDICATION_AND_LEFT.920.aspx},
   year = {2019}
}

TY  - CONF
ID  - 1648037
AU  - Kamasova, M. - Vaclavik, J. - Vaclavik, T. - Kocianova, E. - Jarkovský, Jiří - Benešová, Klára - Jelinek, L. - Taborsky, M.
PY  - 2019
TI  - ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION
KW  - hypertensive patients
KW  - hypertrophy
UR  - https://journals.lww.com/jhypertension/Abstract/2019/07001/ADHERENCE_TO_ANTIHYPERTENSIVE_MEDICATION_AND_LEFT.920.aspx
L2  - https://journals.lww.com/jhypertension/Abstract/2019/07001/ADHERENCE_TO_ANTIHYPERTENSIVE_MEDICATION_AND_LEFT.920.aspx
N2  - According to current registry data, 37% of hypertensive patients reach target blood pressure level. The failure to achieve target blood pressure level cause cardiovascular complications and mortality. Poorly treated arterial hypertension is long-term asymptomatic condition leading to hypertension-mediated organ damage (HMOD), that can be detected by imaging methods and laboratory tests. The aim of our study was to find out the difference in left ventricular (LV) mass values in nonadherent and adherent hypertensive patients.
ER  -

KAMASOVA, M.; J. VACLAVIK; T. VACLAVIK; E. KOCIANOVA; Jiří JARKOVSKÝ; Klára BENEŠOVÁ; L. JELINEK a M. TABORSKY. ADHERENCE TO ANTIHYPERTENSIVE MEDICATION AND LEFT VENTRICULAR HYPERTROPHY IN RESISTANT ARTERIAL HYPERTENSION. In \textit{29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH)}. 2019. ISSN~0263-6352. Dostupné z: https://doi.org/10.1097/01.hjh.0000573932.16624.68.

Přehled o publikaci